Top View
- Qt3r77r0zg.Pdf
- 112, 115 Ab Initio Methods 76 Ab Initio Modeling 55 Abiotic 447 Absorption
- The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
- The Concise Guide to PHARMACOLOGY 2015/16
- Novel Modulation of Adenylyl Cyclase Type 2 Jason Michael Conley Purdue University
- Pharmaceuticals Appendix
- Predicting Drug Responses by Propagating Interactions Through Text-Enhanced Drug-Gene Networks
- Invited Review Neurophysiological Basis of Penile Erection1
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- 1 Drug and Sirna Screens Identify ROCK2 As a Therapeutic Target For
- PDF Poster/Presentation
- Customs Tariff - Schedule
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Electronic Supplementary Material (ESI) for Organic & Biomolecular
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Drug-Resin Complexes Stabilized by Chelating Agents
- (12) United States Patent (10) Patent No.: US 9,050,293 B2 Cohen Et Al
- Known Bioactive Library: Tocriscreen Mini Library 2
- Supplementary Material
- Australian Statistics on Medicines 2009
- Harmonized Tariff Schedule of the United States (2005) Annotated for Statistical Reporting Purposes
- (12) Patent Application Publication (10) Pub. No.: US 2004/0058908A1 Keller Et Al
- The Promise of Inhibition of Smooth Muscle Tone As a Treatment for Erectile Dysfunction: Where Are We Now?
- Inhibition of Renal Rho Kinase Attenuates Ischemia/ Reperfusion-Induced Injury
- (12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
- The Concise Guide to PHARMACOLOGY 2015/16
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- Review Article Present and Future in the Treatment of Diabetic Kidney Disease
- Repurposing Non-Cancer Drugs in Oncology – How Many Drugs Are out There?
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- [Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
- 1 Atorvastatin Calcium 2 Sodium Chloride 3 Clopidogrel 4 Glucose 5
- G Protein-Coupled Receptors As Targets for Approved Drugs: How Many Targets and How Many Drugs? S
- Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Evidence for Rho-Kinase Activation in Patients with Pulmonary Arterial Hypertension
- 1111111111111111111Imnumu
- Large-Scale Phenotype-Based Antiepileptic Drug Screening in a Zebrafish Model of Dravet Syndrome
- Hydroxyfasudil Alleviates Demyelination Through the Inhibition of MOG Antibody and Microglia Activation in Cuprizone Mouse Model T
- An In-Vitro Model to Predict Cardiac Effects of Drugs
- The Rho Kinase Inhibitor Fasudil Inhibits Tumor Progression in Human and Rat Tumor Models
- (12) United States Patent (10) Patent No.: US 7,838,552 B2 Davis Et Al
- ATC Code Title
- Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving